Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 4
1(50.0%)
2Total
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03805607Phase 4Completed

IV Ketorolac on Platelet Function Post-Cesarean Delivery

Role: collaborator

NCT05027048Phase 3Completed

Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery

Role: collaborator

NCT02935556Terminated

Characterization and Epigenetics of Post-Partum Preeclampsia

Role: collaborator

NCT03230110Completed

OSA in Pregnant Women With Chronic HTN

Role: collaborator

All 4 trials loaded